Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Mar. 2026, Natural Alternatives International has a Sloan Ratio of -3.45%, indicating the company is in the safe zone and there is no funny business with accruals.
Natural Alternatives International (NAS:NAII) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Natural Alternatives International has a Sloan Ratio of -3.45%, indicating the company is in the safe zone and there is no funny business with accruals.
Natural Alternatives International Sloan Ratio % Related Terms
Natural Alternatives International Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natural Alternatives International Sloan Ratio % Chart
NAII vs LIMX, FAMI, WYGC: Sloan Ratio % Comparison
For the Packaged Foods subindustry, Natural Alternatives International's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Natural Alternatives International Sloan Ratio % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Natural Alternatives International's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Natural Alternatives International's Sloan Ratio % falls into.
Natural Alternatives International Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Natural Alternatives International's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was -7.216 (Jun. 2025 ) + -0.291 (Sep. 2025 ) + -2.553 (Dec. 2025 ) + -4.311 (Mar. 2026 ) = $-14.4 Mil.
Natural Alternatives International's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 3.345 (Jun. 2025 ) + -4.023 (Sep. 2025 ) + -6.33 (Dec. 2025 ) + 2.503 (Mar. 2026 ) = $-4.5 Mil.
Natural Alternatives International's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was -1.455 (Jun. 2025 ) + -1.03 (Sep. 2025 ) + -0.934 (Dec. 2025 ) + -1.1 (Mar. 2026 ) = $-4.5 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Natural Alternatives International (NAII) has a Sloan Ratio % of -3.45% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Natural Alternatives International and its competitors.
Is Natural Alternatives International's Sloan Ratio % too high?
Natural Alternatives International's current Sloan Ratio % is -3.45%. Overall, Natural Alternatives International has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Natural Alternatives International's Sloan Ratio % compare to LIMX and FAMI?
Natural Alternatives International's Sloan Ratio % of -3.45% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Consumer Packaged Goods company?
A good Sloan Ratio % depends on the Consumer Packaged Goods industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Natural Alternatives International and its competitors. Natural Alternatives International's current Sloan Ratio % is -3.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Natural Alternatives International stock overvalued right now?
Based on GuruFocus' analysis, Natural Alternatives International (NAII) is currently considered Possible Value Trap. The stock's GF Value™ is $5.28, compared to a current price of $2.34 — trading 55.7% below its estimated fair value. The current Sloan Ratio % is -3.45%. Natural Alternatives International's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Natural Alternatives International (NAII), the current Sloan Ratio % is -3.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Natural Alternatives International (NAII) Overvalued in 2026?
Based on GuruFocus' analysis, Natural Alternatives International stock appears to be undervalued.
The current stock price of $2.34 is trading 55.7% below its estimated GF Value™ of $5.28.
GuruFocus considers Natural Alternatives International to be Possible Value Trap.
Key valuation signals for NAII:
Sloan Ratio %: -3.45%
GF Value™: $5.28 vs. price of $2.34 (55.7% below fair value)
No single metric tells the full story. See the NAII stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Natural Alternatives International Business Description
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products, to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segments. The company derives the majority of revenue from Private-Label Contract Manufacturing, which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.
49GF Score
Get the complete analysis for NAII
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NAII has been successfully added to your 
